Dr. Mariette on Takeaways from a Study of Esophageal and Gastric Cancer Surgery

Christophe Mariette, MD, PhD
Published: Monday, Apr 17, 2017



Christophe Mariette, MD, PhD, surgical oncologist, professor of Surgery, University Hospital of Lille, discusses the main takeaways from a study investigating postoperative mortality after patients undergo surgery for esophageal and gastric cancer.

Surgery is not feasible for every patient with esophageal and gastric cancer, explains Mariette. Comorbidities seem to be as important as age based on the results of this study.

When older patients are treated, oncologists should prepare a treatment plan taking both age and comorbidities into account, states Mariette.
 


Christophe Mariette, MD, PhD, surgical oncologist, professor of Surgery, University Hospital of Lille, discusses the main takeaways from a study investigating postoperative mortality after patients undergo surgery for esophageal and gastric cancer.

Surgery is not feasible for every patient with esophageal and gastric cancer, explains Mariette. Comorbidities seem to be as important as age based on the results of this study.

When older patients are treated, oncologists should prepare a treatment plan taking both age and comorbidities into account, states Mariette.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: The Next Generation in Renal Cell Carcinoma Treatment: An Oncology Nursing Essentials WorkshopJul 31, 20181.5
Publication Bottom Border
Border Publication
x